Praxis Für Rheumatologie, Gastroenterologie Und Innere Medizin
- Address
- Romanstrasse 9, 80639 Munich, Germany
Musculoskeletal Diseases
The site focuses on musculoskeletal diseases with a primary emphasis on psoriatic arthritis, testing a new biologic agent to improve joint symptoms and functional outcomes.
- Evaluation of sonelokimab efficacy in reducing disease activity
- Safety monitoring of the investigational biologic
- Comparison with placebo and existing therapies
- Assessment of response in patients naïve to biologic DMARDs
Praxis Für Rheumatologie, Gastroenterologie Und Innere Medizin in Munich is conducting these studies with a dedicated investigator team.
Skin and Connective Tissue Diseases
Research at the centre also addresses skin and connective tissue diseases, specifically the dermatologic manifestations of psoriatic arthritis, aiming to evaluate a novel treatment’s impact on skin lesions and overall quality of life.
- Investigation of sonelokimab effects on skin involvement
- Measurement of patient‑reported outcomes related to skin health
- Safety and tolerability in individuals with prior anti‑TNFα exposure
- Exploration of biomarkers for treatment response
The Munich‑based practice leverages its expertise in rheumatology and dermatology to advance therapeutic options for patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1MoonLake Immunotherapeutics AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1MoonLake Immunotherapeutics AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Praxis Für Rheumatologie, Gastroenterologie Und Innere Medizin
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Subcutaneous Sonelokimab Versus Placebo and Risankizumab in Adults with Active Psoriatic Arthritis and Inadequate Response to TNF-α Inhibitors | MoonLake Immunotherapeutics AG | Phase III | Recruiting | Mar 2025 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sonelokimab | 2 | Unknown | 2025-03-25 | 2025-03-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.